Lymphocyte subsets, apoptosis, and cytokines in patients with chronic fatigue syndrome

Journal of Infectious Diseases

Volumn 173, Issue 2, 1996, Pages 460-463

  Swanink, Caroline M A ^a   Vercoulen, Jan H M M ^b   Galama, Joep M D ^b   Roos, Marijke T L ^b   Meyaard, Linde ^b   Van der Ven Jongekrijg, Johanna ^b   De Nijs, Ron ^b   Bleijenberg, Gijs ^b   Fennis, Jan F M ^b   Miedema, Frank ^b   Van Der Meer, Jos W M ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD38 ANTIGEN; CD8 ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA;

ADULT; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CHRONIC FATIGUE SYNDROME; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE SEVERITY; FEMALE; HUMAN; IMMUNOPHENOTYPING; LYMPHOCYTE SUBPOPULATION; MALE; PRIORITY JOURNAL; PROTEIN SYNTHESIS REGULATION;

EID: 19144365558     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/173.2.460     Document Type: Article

References (17)

1. Sharps MC, Archard LC, Banatvala JE, et al. A report - chronic fatigue syndrome: guidelines for research. J R Soc Med 1991;84:118-21.
2. Caligiuri M, Murray C, Buchwald D, et al. Phenotypic and functional deficiency of natural killer cells in patients with chronic fatigue syndrome. J Immunol 1987;139:3306-13.
3. Klimas NG, Salvato FR, Morgan R, Fletcher MA. Immunologic abnormalities in chronic fatigue syndrome. J Clin Microbiol 1990;28:1403-10.
4. Barker E, Fujimura SF, Faden MB, Landay AL, Levy JA. Immunologic abnormalities associated with chronic fatigue syndrome. Clin Infect Dis 1994;18(suppl 1):S136-41.
5. Lloyd A, Hickie C, Dwyer J, Wakefield D. Cell-mediated immunity in patients with chronic fatigue syndrome, healthy control subjects and patients with major depression. Clin Exp Immunol 1992;87:76-9.
6. Chao CC, Janoff EN, Hu S, et al. Altered cytokine release in peripheral blood mononuclear cell cultures from patients with the chronic fatigue syndrome. Cytokine 1991;3:292-8.
7. Landay AL, Jessop C, Lenette ET, Levy JA. Chronic fatigue syndrome: clinical condition associated with immune activation. Lancet 1991;338:702-12.
8. Linde A, Andersson B, Svenson SB, et al. Serum levels of lymphokines and soluble cellular receptors in primary Epstein-Barr virus infection and in patients with chronic fatigue syndrome. J Infect Dis 1992;165:994-1000.
9. Drenth JPH, van Uum SHM, van Deuren M, Pesman GJ, van der Ven-Jongekrijg J, van der Meer JWM. Endurance run increases circulating IL-6 and IL-IRA but down-regulates ex vivo TNF-α and IL-1β production. J Appl Physiol 1995;79:1497-503.
10. Swanink CMA, Vercoulen JHMM, Bleijenberg G, Fennis JFM, Galama JMD, van der Meer JWM. Chronic fatigue syndrome: a clinical and laboratory study with a well-matched control group. J Int Med 1995;237:499-506.
11. Vercoulen JHMM, Swanink CMA, Fennis JFM, Galama JMD, van der Meer JWM, Bleijenberg G. Dimensional assessment of chronic fatigue syndrome. J Psychosom Res 1994;38:383-92.
12. Roos MTL, Lange JMA, de Goede Y, et al. Viral phenotype and immune response in primary human immunodeficiency virus type 1 infection. J Infect Dis 1992;165:427-32.
13. Meyaard L, Otto SA, Jonker RR, Mijnster MJ, Keet RPM, Miedema F. Programmed cell death of T cells in HIV-1 infection. Science 1992;257:217-9.
14. Gupta S, Vayuvegula B. A comprehensive immunological analysis in chronic fatigue syndrome. Scand J Immunol 1991;33:319-27.
15. Patarca R, Klimas NG, Lugtendorf S, Antoni M, Fletcher MA. Dysregulated expression of tumor necrosis factor in chronic fatigue syndrome: interrelations with cellular sources and patterns of soluble immune mediator expression. Clin Infect Dis 1994;18(suppl 1):S147-53.
16. Nerad JL, Griffiths JK, van der Meer JWM, et al. Interleukin-1β (IL-1β), IL-1 receptor antagonist, and TNF-α production in whole blood. J Leukoc Biol 1992;52:687-92.
17. Van Deuren M, van der Ven-Jongekrijg J, Keuter M, Demacker PMM, van der Meer JWM. Cytokine production in whole blood cultures. J Int Fed Clin Chem 1993;5:216-21.